William B. Burnette

Neurology

2200 Childrens Way # 9
Nashville, TN 37232

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Safety, Tolerability, and Efficacy of a Prophylactic Sirolimus Protocol for Patients Receiving Delandistrogene Moxeparvovec-Rokl Gene Therapy.

Safety, Tolerability, and Efficacy of a Prophylactic Sirolimus Protocol for Patients Receiving Delandistrogene Moxeparvovec-Rokl Gene Therapy.

Journal: Human gene therapy

Published: August 05, 2026

Identification of novel protein biomarkers correlating with both cardiac and skeletal muscle indices in duchenne muscular dystrophy.

Identification of novel protein biomarkers correlating with both cardiac and skeletal muscle indices in duchenne muscular dystrophy.

Journal: Journal of neuromuscular diseases

Published: April 15, 2026

Assessing movement quality in individuals with Duchenne muscular dystrophy utilizing accelerometry: Comparisons with healthy controls.

Assessing movement quality in individuals with Duchenne muscular dystrophy utilizing accelerometry: Comparisons with healthy controls.

Journal: PLOS digital health

Published: March 05, 2026

Six-Minute Activity-95th Centile, a Novel Wearable-Derived Clinical Outcome Assessment for Duchenne Muscular Dystrophy.

Six-Minute Activity-95th Centile, a Novel Wearable-Derived Clinical Outcome Assessment for Duchenne Muscular Dystrophy.

Journal: Pediatric neurology

Published: August 29, 2025

Reversal of Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Using Sirolimus and Immunoglobulin.

Reversal of Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Using Sirolimus and Immunoglobulin.

Journal: Pediatric neurology

Published: May 16, 2025

Physical activity and cardiac function in patients with Duchenne muscular dystrophy.

Physical activity and cardiac function in patients with Duchenne muscular dystrophy.

Journal: Cardiology in the young

Published: February 27, 2025

Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin.

Acute Liver Injury Following Delandistrogene Moxeparvovec Gene Therapy Requiring Intravenous Immunoglobulin.

Journal: Pediatric neurology

Published: July 06, 2024

Access to novel therapies for Duchenne muscular dystrophy-Insights from expert treating physicians.

Access to novel therapies for Duchenne muscular dystrophy-Insights from expert treating physicians.

Journal: Annals of the Child Neurology Society

Published: May 08, 2024

Physical Activity Correlates With Skeletal Muscle MRI Findings in Individuals With Duchenne Muscular Dystrophy.

Physical Activity Correlates With Skeletal Muscle MRI Findings in Individuals With Duchenne Muscular Dystrophy.

Journal: Muscle & nerve

Published: April 10, 2024

Survival in eteplirsen-treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?

Survival in eteplirsen-treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?

Journal: Muscle & nerve

Published: April 01, 2024

Spinal Muscular Atrophy Update in Best Practices: Recommendations for Treatment Considerations.

Spinal Muscular Atrophy Update in Best Practices: Recommendations for Treatment Considerations.

Journal: Neurology. Clinical practice

Published: November 27, 2023

Spirometry correlates with physical activity in patients with Duchenne muscular dystrophy.

Spirometry correlates with physical activity in patients with Duchenne muscular dystrophy.

Journal: Pediatric pulmonology

Published: June 14, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026